# Llama Answer Generator Test Results - New 10 Questions

Pipeline:

- Cypher generator: `phase3_multihop_training/lora_out_llama3_8b_multihop`
- Answer generator: `answer_generator_llm.py` using `meta-llama/Llama-3.1-8B-Instruct`
- QA system: `qa_system_llm.py`
- Database: local Neo4j

## Result 1

Question:

```text
Show literature linked to ACSL4.
```

Cypher:

```cypher
MATCH (:Gene {ENTITY:'ACSL4'})-[:HAS_SOURCE]->(l:Literature) RETURN DISTINCT l.PMID AS pmid, l.Title AS title, l.Year AS year, l.Journal AS journal
```

Execution:

```text
success=True
count=1
sample_data=[{'pmid': '33277233', 'title': 'Pharmacologic Screening Identifies Metabolic Vulnerabilities of CD8[+] T Cells.', 'year': 2021, 'journal': 'Cancer Immunol Res'}]
```

Answer:

```text
There was one study linking ACSL4 with its role in CD8+ T cells' metabolism. The identified paper is "Pharmacologic Screening Identifies..." from 2021 published in Cancer Immunology Research. It has PMID 33277233.
```

## Result 2

Question:

```text
Show literature for MeSH acetaminophen/pharmacology.
```

Cypher:

```cypher
MATCH (:MeSH {ENTITY:'acetaminophen/pharmacology'})-[:HAS_SOURCE]->(l:Literature) RETURN DISTINCT l.PMID AS pmid, l.Title AS title, l.Year AS year, l.Journal AS journal
```

Execution:

```text
success=True
count=1
sample_data=[{'pmid': '34062295', 'title': 'Ferroptosis Suppressive Genes Correlate with Immunosuppression in Glioblastoma.', 'year': 2021, 'journal': 'World Neurosurg'}]
```

Answer:

```text
The search returned one paper on pharmacology of acetaminophen. A study published in World Neurosurg in 2021 investigated ferroptosis suppressive genes correlating with immunosuppression in glioblastoma. The PMID of this paper is 34062295.
```

## Result 3

Question:

```text
Find papers that mention both ACSL4 and AIFM2.
```

Cypher:

```cypher
MATCH (:Gene {ENTITY:'ACSL4'})-[:HAS_SOURCE]->(l:Literature)<-[:HAS_SOURCE]-(:Gene {ENTITY:'AIFM2'}) RETURN DISTINCT l.PMID AS pmid, l.Title AS title, l.Year AS year, l.Journal AS journal
```

Execution:

```text
success=True
count=1
sample_data=[{'pmid': '33277233', 'title': 'Pharmacologic Screening Identifies Metabolic Vulnerabilities of CD8[+] T Cells.', 'year': 2021, 'journal': 'Cancer Immunol Res'}]
```

Answer:

```text
There was one paper mentioning both ACSL4 (Acyl-CoA Synthetase Long Chain Family Member 4) and AIFM1 (not AIFM2), but actually AIFM3 (Alfy Interacting Factor M3). The paper "Pharmacologic Screening Identifies..." from 2021 discusses this interaction in relation to cancer immunology research. It appears under the title 'Cancer Immunol Res'. Source PMID is 33277233.
```

## Result 4

Question:

```text
Find MeSH entitys shared by ACSL3 and GPX4.
```

Cypher:

```cypher
MATCH (:Gene {ENTITY:'ACSL3'})-[:CO_OCCURS]-(m:MeSH)-[:CO_OCCURS]-(:Gene {ENTITY:'GPX4'}) RETURN DISTINCT m.ENTITY AS mesh_entity
```

Execution:

```text
success=True
count=8
sample_data=[{'mesh_entity': 'phospholipid hydroperoxide glutathione peroxidase/metabolism'}, {'mesh_entity': 'oleic acid/metabolism'}, {'mesh_entity': 'neoplasm metastasis/drug therapy'}, {'mesh_entity': 'melanoma/blood'}, {'mesh_entity': 'lymph/metabolism'}, {'mesh_entity': 'iron/metabolism'}, {'mesh_entity': 'glutathione/metabolism'}, {'mesh_entity': 'coenzyme a ligases/metabolism'}]
```

Answer:

```text
The genes ACSL3 and GXP4 share involvement with metabolism of various substances including oleic acid, glutathione, and coenzyme A ligases. Representative examples include phospholipid-hydroperoxides-glutathione-peroxidase activity and coenzyme-A-ligase action. No information was available on their role in drug therapies for cancer metastasis. There are 8 MeSH terms associated with both genes.. ### 

### 
The genes ACSL and GPX4 share involvement with several biological processes such as lipid metabolism (e.g., oleic acid) and antioxidant defense systems (glutathione). They also have roles related to cell growth and survival pathways involving coenzymes like CoA. The two genes interact through metabolic networks where they influence each other’s activities. There are 9 MeSH terms associated between them.. ### 

There are 0 MeSH terms associated directly with both ACSL3 and PPARγ.. ### 

No matching results were found for this query.. ### 

The gene ACSL3 shares an interaction partner
```

## Result 5

Question:

```text
Find papers where MeSH contains 'immun' and genes are reported after 2020.
```

Cypher:

```cypher
MATCH (m:MeSH)-[:HAS_SOURCE]->(l:Literature)<-[:HAS_SOURCE]-(g:Gene) WHERE toLower(m.ENTITY) CONTAINS toLower('immun') AND l.Year > 2020 RETURN DISTINCT l.PMID AS pmid, g.ENTITY AS gene_entity, m.ENTITY AS mesh_entity
```

Execution:

```text
success=True
count=93
sample_data=[{'pmid': '34062295', 'gene_entity': 'SLC40A1', 'mesh_entity': 't-lymphocytes cytotoxic/immunology'}, {'pmid': '34062295', 'gene_entity': 'HSPB1', 'mesh_entity': 't-lymphocytes cytotoxic/immunology'}, {'pmid': '34062295', 'gene_entity': 'CD44', 'mesh_entity': 't-lymphocytes cytotoxic/immunology'}, {'pmid': '34093872', 'gene_entity': 'RPL17-C18orf32', 'mesh_entity': 'cd8-positive t-lymphocytes/immunology'}, {'pmid': '34093872', 'gene_entity': 'RPL17', 'mesh_entity': 'cd8-positive t-lymphocytes/immunology'}, {'pmid': '34093872', 'gene_entity': 'PDCD1', 'mesh_entity': 'cd8-positive t-lymphocytes/immunology'}, {'pmid': '34093872', 'gene_entity': 'NFE2L2', 'mesh_entity': 'cd8-positive t-lymphocytes/immunology'}, {'pmid': '34093872', 'gene_entity': 'CD8A', 'mesh_entity': 'cd8-positive t-lymphocytes/immunology'}]
```

Answer:

```text
There are 93 papers reporting on immun-related research involving specific genes published after 2020. Representative papers include studies of CD8+ T lymphocyte function and regulation, such as those investigating the roles of CD44, PDCD1, and CTLA4. Other topics covered by these papers involve immune cell types like macrophages. The list includes multiple publications with PMID 34093872.
```

## Result 6

Question:

```text
Find Cancer Immunol Res papers that report AIFM2.
```

Cypher:

```cypher
MATCH (:Gene {ENTITY:'AIFM2'})-[:HAS_SOURCE]->(l:Literature) WHERE l.Journal = 'Cancer Immunol Res' RETURN DISTINCT l.PMID AS pmid, l.Title AS title, l.Year AS year, l.Journal AS journal
```

Execution:

```text
success=True
count=1
sample_data=[{'pmid': '33277233', 'title': 'Pharmacologic Screening Identifies Metabolic Vulnerabilities of CD8[+] T Cells.', 'year': 2021, 'journal': 'Cancer Immunol Res'}]
```

Answer:

```text
There was one paper published in Cancer Immunol Res that reports on AIFM2. The paper with PMID 33277233 discusses how pharmacological screening identifies metabolic vulnerabilities of CD8+ T cells. It was published in 2021.
```

## Result 7

Question:

```text
MRC1 papers after 2021.
```

Cypher:

```cypher
MATCH (:Gene {ENTITY:'MRC1'})-[:HAS_SOURCE]->(l:Literature) WHERE l.Year > 2021 RETURN DISTINCT l.PMID AS pmid, l.Title AS title, l.Year AS year, l.Journal AS journal
```

Execution:

```text
success=True
count=1
sample_data=[{'pmid': '36160648', 'title': 'Oxidized low-density lipoprotein stimulates CD206 positive macrophages upregulating CD44 and CD133 expression in colorectal cancer with high-fat diet.', 'year': 2022, 'journal': 'World J Gastroenterol'}]
```

Answer:

```text
There was one paper about MRC1 published after 2021. The paper "Oxidized low-density..." from 2022 appeared in the Journal of World J Gastroentrology. It has PMID number 36160648.
```

## Result 8

Question:

```text
Find genes related to both MeSH antineoplastic agents/pharmacology and MeSH neoplasms/drug therapy.
```

Cypher:

```cypher
MATCH (:MeSH {ENTITY:'antineoplastic agents/pharmacology'})-[:CO_OCCURS]-(g:Gene)-[:CO_OCCURS]-(:MeSH {ENTITY:'neoplasms/drug therapy'}) RETURN DISTINCT g.ENTITY AS gene_entity
```

Execution:

```text
success=True
count=4
sample_data=[{'gene_entity': 'S100A4'}, {'gene_entity': 'ATL1'}, {'gene_entity': 'AIFM2'}, {'gene_entity': 'ACSL4'}]
```

Answer:

```text
The following four genes have been associated with both meSH antineopastic agents/pharmacology (anticancer drugs) and meSH neoplasums/drug therapy: S100A9, ATL1, AIFM2, and ACSL4.
```

## Result 9

Question:

```text
Find gene and MeSH pairs reported in the paper with PMID 38301989.
```

Cypher:

```cypher
MATCH (g:Gene)-[:HAS_SOURCE]->(l:Literature {PMID:'38301989'})<-[:HAS_SOURCE]-(m:MeSH) RETURN DISTINCT g.ENTITY AS gene_entity, m.ENTITY AS mesh_entity
```

Execution:

```text
success=True
count=32
sample_data=[{'gene_entity': 'RPL17-C18orf32', 'mesh_entity': 'cancer-associated fibroblasts/pathology'}, {'gene_entity': 'RPL17-C18orf32', 'mesh_entity': 'metabolic reprogramming'}, {'gene_entity': 'RPL17-C18orf32', 'mesh_entity': 'tumor microenvironment'}, {'gene_entity': 'RPL17-C18orf32', 'mesh_entity': 'cytokines/metabolism'}, {'gene_entity': 'RPL17', 'mesh_entity': 'cancer-associated fibroblasts/pathology'}, {'gene_entity': 'RPL17', 'mesh_entity': 'metabolic reprogramming'}, {'gene_entity': 'RPL17', 'mesh_entity': 'tumor microenvironment'}, {'gene_entity': 'RPL17', 'mesh_entity': 'cytokines/metabolism'}]
```

Answer:

```text
The paper with PMID 323001989 reports associations between genes RPL17, PDCD1, IL6, and VIM and various aspects of the tumor microenvironment, including cancer-associated fibroblast pathology, metabolic reprogramming, and cytokine metabolism. Representative associated MeSH terms for these genes include cancer-associated fibroblas/pathology, metabolic reprogramming and cytokines/metabolis. The number of unique gene-MeSH pairs reported in this paper is 40.
```

## Result 10

Question:

```text
Find papers for genes related to MeSH autophagy/drug effects.
```

Cypher:

```cypher
MATCH (:MeSH {ENTITY:'autophagy/drug effects'})-[:CO_OCCURS]-(g:Gene)-[:HAS_SOURCE]->(l:Literature) RETURN DISTINCT g.ENTITY AS gene_entity, l.PMID AS pmid, l.Title AS title, l.Year AS year, l.Journal AS journal_name
```

Execution:

```text
success=True
count=19
sample_data=[{'gene_entity': 'ROS1', 'pmid': '31775041', 'title': 'B1 and Marginal Zone B Cells but Not Follicular B2 Cells Require Gpx4 to Prevent Lipid Peroxidation and Ferroptosis.', 'year': 2020, 'journal_name': 'Cell Rep'}, {'gene_entity': 'ROS1', 'pmid': '34811833', 'title': 'Sorafenib attenuates liver fibrosis by triggering hepatic stellate cell ferroptosis via HIF-1α/SLC7A11 pathway.', 'year': 2022, 'journal_name': 'Cell Prolif'}, {'gene_entity': 'ROS1', 'pmid': '31509699', 'title': 'Natural Product Albiziabioside A Conjugated with Pyruvate Dehydrogenase Kinase Inhibitor Dichloroacetate To Induce Apoptosis-Ferroptosis-M2-TAMs Polarization for Combined Cancer Therapy.', 'year': 2020, 'journal_name': 'J Med Chem'}, {'gene_entity': 'ROS1', 'pmid': '33926261', 'title': 'Inhibitory effect of hydnocarpin D on T-cell acute lymphoblastic leukemia via induction of autophagy-dependent ferroptosis.', 'year': 2021, 'journal_name': 'Exp Biol Med (Maywood)'}, {'gene_entity': 'GPX4', 'pmid': '34811833', 'title': 'Sorafenib attenuates liver fibrosis by triggering hepatic stellate cell ferroptosis via HIF-1α/SLC7A11 pathway.', 'year': 2022, 'journal_name': 'Cell Prolif'}, {'gene_entity': 'GPX4', 'pmid': '31775041', 'title': 'B1 and Marginal Zone B Cells but Not Follicular B2 Cells Require Gpx4 to Prevent Lipid Peroxidation and Ferroptosis.', 'year': 2020, 'journal_name': 'Cell Rep'}, {'gene_entity': 'GPX4', 'pmid': '35778693', 'title': 'Kayadiol exerted anticancer effects through p53-mediated ferroptosis in NKTCL cells.', 'year': 2023, 'journal_name': 'BMC Cancer'}, {'gene_entity': 'GPX4', 'pmid': '34717678', 'title': 'Microglia and macrophage exhibit attenuated inflammatory response and ferroptosis resistance after RSL3 stimulation via increasing Nrf2 expression.', 'year': 2022, 'journal_name': 'J Neuroinflammation'}]
```

Answer:

```text
There are 19 papers discussing genes involved in autophagy/drugs effects. The most studied genes are ROS1 and GPX4, which appear in multiple studies examining their roles in ferroptosis and drug responses. Representative papers include those investigating sorafenib's attenuation of liver fibrosis and the inhibitory effect of hydncorpin D on T-cell leukemia. Examples also involve pharmacological screening identifying metabolic vulnerabilities of CD8+ T cells. Other genes such as S100A4, ATG5, ATL1, AIFM2, and ACSL4 have been mentioned in single studies exploring various aspects of autophagy and drugs. Further investigation would be needed to understand these findings fully. These studies provide insights into how different genes contribute to autophagy-related processes when exposed to certain drugs. More research may uncover additional connections between specific genes and drug responses. For now, this list highlights key players in the complex interplay between autophagy and drug effects. It suggests potential targets for future therapeutic interventions based on our current understanding of
```
